Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of Capecitabine Pharmacokinetics and Hand-foot Syndrome in CES1 Variant Carriers: the ESCAPE Study

NCT07114627 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07114627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07114627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of Capecitabine Pharmacokinetics and Hand-foot Syndrome in CES1 Variant Carriers: the ESCAPE Study
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
February 18, 2025
Completion date
June 30, 2027
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), esophageal cancer, gastric (cardia, body) cancer, solid cancer